Eagle Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Cash & Equivalents	55.32	97.66	103.16	109.78	78.79	114.66	52.82	79.08	22.72	10.46	Upgrade
Short-Term Investments	0	0	0	0	0	0	0	0	20	0	Upgrade
Cash & Cash Equivalents	55.32	97.66	103.16	109.78	78.79	114.66	52.82	79.08	42.72	10.46	Upgrade
Cash Growth	-43.35%	-5.33%	-6.03%	39.32%	-31.28%	117.07%	-33.21%	85.12%	308.58%	59.22%	Upgrade
Receivables	72.44	41.15	51.12	48	66.49	53.82	42.19	26.27	7.3	5.12	Upgrade
Inventory	47.79	21.91	8.08	6.57	8.3	5.12	2.74	15.04	1.29	0	Upgrade
Other Current Assets	13.2	11.89	3.72	15.1	10.26	15.1	11.36	1.87	1.71	1.9	Upgrade
Total Current Assets	188.75	172.61	166.07	179.45	163.84	188.7	109.11	122.26	53.02	17.48	Upgrade
Property, Plant & Equipment	1.17	1.64	2.08	2.2	2.4	6.82	3.32	2.21	0.34	0.4	Upgrade
Goodwill and Intangibles	163.36	50.41	52.66	55.33	57.85	63.07	73.12	0	0	0	Upgrade
Other Long-Term Assets	52.88	29.08	32.39	17.58	14.52	11.48	28.78	0.14	0.05	0.22	Upgrade
Total Long-Term Assets	217.41	81.13	87.13	75.11	74.76	81.36	105.21	2.35	0.39	0.62	Upgrade
Total Assets	406.16	253.73	253.19	254.55	238.6	270.06	214.32	124.61	53.41	18.1	Upgrade
Accounts Payable	18.99	16.43	6.27	5.46	9.92	11.98	14.72	3.86	4.06	1.19	Upgrade
Deferred Revenue	0	0	0	0	0	0	0	6	6.59	10.02	Upgrade
Current Debt	6.25	25.61	8	5	6.25	4.88	0	0	0	0	Upgrade
Other Current Liabilities	85.84	32.34	23.82	28.36	23.52	30.45	26.25	24.41	9.67	3.13	Upgrade
Total Current Liabilities	111.09	74.38	38.09	38.82	39.69	47.3	40.97	34.26	20.32	14.34	Upgrade
Long-Term Debt	56.22	0	25.14	33.56	38.16	42.91	0	0	0	0	Upgrade
Other Long-Term Liabilities	5.3	2.9	3.96	3	0	0.71	22.13	0	0	91.69	Upgrade
Total Long-Term Liabilities	61.51	2.9	29.09	36.56	38.16	43.61	22.13	0	0	91.69	Upgrade
Total Liabilities	172.6	77.28	67.18	75.38	77.84	90.92	63.09	34.26	20.32	106.03	Upgrade
Total Debt	62.47	25.61	33.14	38.56	44.41	47.78	0	0	0	0	Upgrade
Debt Growth	143.94%	-22.72%	-14.06%	-13.17%	-7.06%	-	-	-	-	-	Upgrade
Retained Earnings	111.5	75.86	84.49	72.5	58.19	26.28	-25.66	-107.11	-104.18	-102.14	Upgrade
Comprehensive Income	-1.11	-0.09	0	0	0	0	0	0	0	0	Upgrade
Shareholders' Equity	233.56	176.45	186.01	179.17	160.76	179.14	151.23	90.34	33.1	-87.93	Upgrade
Net Cash / Debt	-7.15	72.05	70.02	71.22	34.39	66.88	52.82	79.08	42.72	10.46	Upgrade
Net Cash / Debt Growth	-	2.90%	-1.68%	107.11%	-48.58%	26.61%	-33.21%	85.12%	308.58%	-	Upgrade
Net Cash Per Share	-0.55	5.52	5.08	5.04	2.25	4.20	3.21	4.87	4.29	3.43	Upgrade
Working Capital	77.67	98.23	127.98	140.63	124.16	141.4	68.15	88	32.71	3.14	Upgrade
Book Value Per Share	18.06	13.52	13.80	13.03	10.88	11.86	9.73	5.92	3.32	-28.88	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).